decitabine
- Product NDC
- 68180-738
- 11-digit product format
- 681800738
- Labeler code
- 68180
- Product ID
- 68180-738_f7db1754-5eb9-453e-b247-470517492676
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- decitabine
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Lupin Pharmaceuticals, Inc.
- Application
- ANDA210756
- Marketing category
- ANDA
- Marketing start
- 2019-12-06
- Marketing end
- 0000-00-00
- Substance
- DECITABINE
- Active strength
- 50 mg/20mL
- Pharmacologic classes
- Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68180-738-01 | decitabine | 1 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 1 | | 6 |
| 68180-738-01 | decitabine | 20 mL in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 20 | | 6 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68180-738 | DECITABINE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [LUPIN PHARMACEUTICALS, INC.] | 6 | Legacy NDC, 2 package rows | 20231215_79d5d5e3-f782-44e9-b422-664d9371647e.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68180-738-01 | 68180073801 | 1 VIAL in 1 CARTON (68180-738-01) > 20 mL in 1 VIAL | 1 vial | 2019-12-06 | 0000-00-00 | No | No | Current |